Q301--Specialized Genetic Testing Services

Solicitation / RFP / RFQ

This document is a solicitation for Specialized Genetic Testing Services for the Department of Veterans Affairs, Network Contracting Office 17. The contracting office is located in San Antonio, TX (ZIP code 78240).

This solicitation pertains to Product Service Code Q301 and NAICS Code 621511. Specific details regarding the required services or deliverables are not fully detailed in the provided text, but it is related to genetic testing.

This appears to be an award notice, not a solicitation document itself. The award number is 36C25726D0054, with an award date of 02-26-2026 and an award amount of $62,145.00.

Information regarding proposal submission or evaluation criteria is not present in this excerpt.

No specific set-aside information is provided in this excerpt.

This document appears to be an award notice rather than a solicitation. The awardee is AMBRY GENETICS CORPORATION, with UEI E1VBXEM76NC5, located in Aliso Viejo, CA (ZIP code 92656).

Solicitation / RFP / RFQ

This solicitation is for Specialized Genetic Laboratory Testing and guidance in Exome and Genomic tests, Oncology, and Pathology services for eligible Veterans Affairs (VA) beneficiaries of the South Texas Veterans Health Care System (STVHCS). The services are to be provided at the Audie L. Murphy Division located in San Antonio, TX.

• Provide personnel, labor, transportation, equipment, materials, and supplies for specialized genetic laboratory testing.

• Perform complementary studies to reduce variants of unknown significance (VUS) and provide evidence of supporting variant classifications.

• Conduct targeted RNA analysis and DNA tandem analysis to define VUS as benign or pathogenic.

• Offerors must provide tests in-house and meet brand name or equal specifications for "Cancer Next" and "Colo Next+ RNA Insight" tests.

• Maintain a secure online portal for test ordering, tracking, and result reporting.

• Provide timely testing with specified Turn-Around-Times (TAT) of 14-21 days for listed tests.

• Provide daily reports on incomplete specimens and monthly utilization reports.

• Laboratory must be fully licensed, accredited, and certified by relevant agencies (e.g., CAP, CLIA, Joint Commission, AABB).

• Contractor must comply with HIPAA and provide National Provider Identifier (NPI) information.

• This is a Single Award, Firm-Fixed Price, Indefinite Delivery Indefinite Quantity (IDIQ) Contract.

• Guaranteed minimum award amount: $10,000.00.

• Maximum aggregate value of orders: $72,000.00.

• Ordering Periods: Five periods from 03/29/2026 to 03/28/2031.

• Contract type: Firm-Fixed-Price (FFP).

• Technical questions due by 01/21/2026, 11:00 AM EST to Kathryn Prose (kathryn.prose@va.gov).

• Offers due by 01/29/2026, 1:00 PM EST.

• Submission via email to Kathryn Prose.

• Evaluation factors: Technical, Past Performance, and Price.

• Offers will be evaluated using a comparative process to determine the most advantageous to the Government.

• Technical evaluation will assess the ability to meet all Statement of Work requirements.

• Past Performance will be evaluated using CPARS reports from the past five years.

• Price will be evaluated for reasonableness, completeness, and fairness.

• This acquisition is UNRESTRICTED or SET ASIDE.

• NAICS Code: 621511 (Medical Laboratories).

• Size Standard: $41.5 Million.

• Offerors must complete SF 1449, blocks 17a and b, and 30a through c.

• Technical documentation, including a list of laboratories and a sample final report, is required.

• Quotes must demonstrate brand name or equal compliance.

• Offerors agree to hold prices for 90 calendar days from the closing date.

Solicitation / RFP / RFQ

This is a combined synopsis/solicitation for commercial products and services for Specialized Genetic Laboratory Testing and studies to reduce variants of unknown significance (VUS). The VA South Texas Healthcare System is requesting brand name or equal testing.

• CancerNext Testing: Includes a specific list of genes (e.g., APC, ATM, BRCA1, BRCA2, TP53).

• ColoNext Plus RNA Insight: Includes a specific list of genes for both DNA and RNA analysis.

• VUS Reduction: Must provide complementary studies to reduce variants of unknown significance (VUS) and evidence supporting variant classifications in final reports.

• Specialized Studies: Must perform targeted RNA analysis of splicing variants and RNA/DNA tandem analysis.

• Laboratory Accreditation: Must be fully licensed, accredited (e.g., CAP, CLIA), and inspected by relevant agencies (CMS, CDC, state agencies, Joint Commission, AABB as applicable).

• Compliance: Must meet requirements of CLIA '88, HIPAA, and VHA Directive 1106.

• Brand Name or Equal: Tests must be brand name or equal to the descriptions provided.

• Contracting Office: Department of Veterans Affairs, Network Contracting Office 17, San Antonio, TX.

• Place of Performance: VA South Texas Veterans Health Care System, San Antonio, TX.

• Product Service Code: Q301

• NAICS Code: 621511 (Small business size standard: $41.5 million)

• Response Date/Time: January 29, 2026, 1:00 PM Eastern Time.

• Submission Method: Email to Kathryn Prose (kathryn.prose@va.gov) with specific subject line.

• Evaluation Factors: Comparative evaluation based on Technical Capability, Past Performance, and Price.

• Technical Capability: Must clearly demonstrate ability to meet all SOW requirements.

• Past Performance: Evaluated using CPARS reports from the past five years.

• Price: Evaluated for reasonableness, completeness, and fairness.

• Options: Evaluation of option to extend services under FAR 52.217-8 will be considered.

• Technical Questions Deadline: January 21, 2026, 11:00 AM EST via email.

• Unrestricted solicitation.

• The solicitation is issued as an RFQ and incorporates provisions and clauses effective through Federal Acquisition Circular 2025-06.

• Award will be made to the responsible offeror whose quote is most advantageous to the Government.

• Offerors must submit a technical quotation package, price quote, signed SF-1449, and evidence of compliance.

• Prices must be held firm for 90 calendar days from the closing date.